Details of Host Protein-DME Interaction (HOSPPI)
| General Information of Drug-Metabolizing Enzyme (DME ID: DME0206) | |||||
|---|---|---|---|---|---|
| DME Name | Sodium/potassium-transporting ATPase gamma (FXYD2), Homo sapiens | DME Info | |||
| UniProt ID | |||||
| EC Number | EC: 3.6.1.- (Click to Show/Hide the Complete EC Tree) | ||||
| Lineage | Species: Homo sapiens (Click to Show/Hide the Complete Species Lineage) | ||||
| Interactome | |||||
| Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
|---|---|---|---|---|---|
| ICD Disease Classification 02 Neoplasms | |||||
| ICD-11: 2B30 Lymphoma | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| DNA methylation | |||||
| DNA methyltransferase (DNMT) | Lymphoma | Significant hypomethylation | |||
| Interaction Name | DNMT-FXYD2 interaction | ||||
| The Methylation Level of Disease Section Compare with the Healthy Individual Tissue | Significant hypomethylation p-value: 9.97E-11; delta-beta: -3.88E-01 | ||||
| Description | DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the FXYD2 gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Sodium/potassium-transporting ATPase gamma. As a result, the interaction between DNMT and FXYD2 can significantly affect the drug-metabolizing process of Sodium/potassium-transporting ATPase gamma. | ||||
|
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
|
|||||
| Violin Diagram of DME Disease-specific Methylation Level |
|
Click to View the Clearer Original Diagram | |||
| ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases | |||||
| ICD-11: 5C50 Phenylketonuria | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| Transcription-factor regulation | |||||
| Dimerization cofactor of HNF1 (PCBD1) | Hyperphenylalaninemia | Repression | |||
| Uniprot ID | |||||
| Interaction Name | PCBD1-FXYD2 interaction | [1] | |||
| Studied Cell Lines | HEK293 cell line | ||||
| Description | Dimerization cofactor of HNF1 (PCBD1) is reported to repress the transcription of FXYD2 gene, which leads to a decreased expression of the drug-metabolizing enzyme Sodium/potassium-transporting ATPase gamma. As a result, the interaction between PCBD1 and FXYD2 can repress the drug-metabolizing process of Sodium/potassium-transporting ATPase gamma. | ||||
| ICD-11: 5C59 Primapterinuria | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
| Transcription-factor regulation | |||||
| Dimerization cofactor of HNF1 (PCBD1) | Primapterinuria | Repression | |||
| Uniprot ID | |||||
| Interaction Name | PCBD1-FXYD2 interaction | [1] | |||
| Studied Cell Lines | HEK293 cell line | ||||
| Description | Dimerization cofactor of HNF1 (PCBD1) is reported to repress the transcription of FXYD2 gene, which leads to a decreased expression of the drug-metabolizing enzyme Sodium/potassium-transporting ATPase gamma. As a result, the interaction between PCBD1 and FXYD2 can repress the drug-metabolizing process of Sodium/potassium-transporting ATPase gamma. | ||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Mutations in PCBD1 cause hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol. 2014 Mar;25(3):574-86. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

